Inogen
INGN
135 hedge funds and large institutions have $409M invested in Inogen in 2022 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 67 increasing their positions, 29 reducing their positions, and 21 closing their positions.
131% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 29
2.87% less ownership
Funds ownership: 96.85% → 93.98% (-2.9%)
7% less funds holding
Funds holding: 145 → 135 (-10)
24% less capital invested
Capital invested by funds: $538M → $409M (-$129M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
43% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 21
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $49K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$11.9M |
| 2 |
Millennium Management
New York
|
+$3.23M |
| 3 |
BlackRock
New York
|
+$3.08M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$2.83M |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$2.44M |
Top Sellers
INGN Hedge Fund Activity: Q4 2022 in Review
135 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Inogen (INGN) for Q4 2022, worth a combined $409M — down 24% from $538M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of INGN and 12 opened new positions — a net loss of 9 holders — while 29 trimmed existing stakes and 67 added.
The largest buyer was Morgan Stanley, adding an estimated $11.9M. The largest seller was Brown Capital Management, cutting an estimated $20.8M.
- 135 institutional investors held Inogen (INGN) as of Q4 2022, down from 145 in Q3 2022.
- Funds reported $409M of Inogen stock for Q4 2022, down 24% quarter-over-quarter.
- 12 funds opened new Inogen positions in Q4 2022 and 21 closed out, a net change of -9 holders.
- The largest Inogen buyer in Q4 2022 was Morgan Stanley, an estimated $11.9M added.
- The largest Inogen seller in Q4 2022 was Brown Capital Management, an estimated $20.8M sold.
Based on aggregated 13F filings for Q4 2022.